Understanding how aging affects treatment outcomes in older adults with colorectal cancer
Geriatric assessment domains in relation to treatment outcomes among older adults with colorectal cancer
This study is looking at how getting older affects the success of treatments for older adults with colorectal cancer, so we can better personalize care and improve their quality of life.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Utah NIH-funded |
| Lab location | 1 site (Salt Lake City, United States) |
| Project ID | NIH-11132889 on NIH RePORTER |
What this research studies
This research investigates the impact of aging on treatment outcomes for older adults diagnosed with colorectal cancer. It aims to evaluate various factors such as physical function, a brief geriatric assessment tool, and specific biomarkers related to aging. By analyzing these elements, the study seeks to improve clinical decision-making and tailor treatment plans that minimize complications and enhance the quality of life for older patients. The research will focus on understanding how these aging-related factors influence surgical outcomes and overall patient well-being.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults aged 70 and above who have been diagnosed with colorectal cancer.
Not a fit: Patients who are younger than 70 or those without a diagnosis of colorectal cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and effective treatment strategies for older adults with colorectal cancer, ultimately improving their survival rates and quality of life.
How similar studies have performed: Previous research has shown that tailored approaches considering aging factors can improve outcomes in older cancer patients, suggesting this study builds on established concepts.
Where this research is happening
Salt Lake City, United States
- University of Utah — Salt Lake City, United States (Active)
Researchers
- Principal investigator: Hardikar, Sheetal — University of Utah
- Study coordinator: Hardikar, Sheetal
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.